Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 31, 2017

AbbVie Inc. v. Novartis Vaccines and Diagnostics, Inc. et al

Track this case

Case overview

Case Number:

3:17-cv-01815

Court:

California Northern

Nature of Suit:

Patent

Judge:

Edward M. Chen

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 31, 2017

    Unclear Grammar Lands AbbVie-Novartis IP Row In Arbitration

    A California federal judge on Thursday sent AbbVie Inc.'s suit seeking to nix Novartis' hepatitis C patents to arbitration, finding that while a licensing agreement between the companies was so grammatically unclear he consulted his Chicago Manual of Style, the ambiguity triggers a presumption in favor of the Federal Arbitration Act.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login